Your browser doesn't support javascript.
loading
Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer in CheckMate 227.
Brahmer, Julie R; Lee, Jong-Seok; Ciuleanu, Tudor-Eliade; Bernabe Caro, Reyes; Nishio, Makoto; Urban, Laszlo; Audigier-Valette, Clarisse; Lupinacci, Lorena; Sangha, Randeep; Pluzanski, Adam; Burgers, Jacobus; Mahave, Mauricio; Ahmed, Samreen; Schoenfeld, Adam J; Paz-Ares, Luis G; Reck, Martin; Borghaei, Hossein; O'Byrne, Kenneth J; Gupta, Ravi G; Bushong, Judith; Li, Li; Blum, Steven I; Eccles, Laura J; Ramalingam, Suresh S.
Afiliación
  • Brahmer JR; Johns Hopkins Kimmel Cancer Center, Baltimore, MD.
  • Lee JS; National University Bundang Hospital, Seongnam, Republic of Korea.
  • Ciuleanu TE; Institutul Oncologic Prof Dr Ion Chiricuta and University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania.
  • Bernabe Caro R; Hospital Universitario Virgen Del Rocio, Instituto de Biomedicina de Seville, Seville, Spain.
  • Nishio M; Department of Thoracic Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Urban L; Matrai Gyogyintezet, Mátraháza, Hungary.
  • Audigier-Valette C; Orientation Oncologique, Hôpital Sainte Musse, Toulon, France.
  • Lupinacci L; Hospital Italiano De Buenos Aires, Buenos Aires, Argentina.
  • Sangha R; Cross Cancer Institute, Edmonton, AB, Canada.
  • Pluzanski A; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Burgers J; Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Mahave M; Instituto Oncológico Fundación Arturo López Pérez, Santiago, Chile.
  • Ahmed S; University Hospitals of Leicester NHS Trust, Infirmary Square, Leicester, United Kingdom.
  • Schoenfeld AJ; Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY.
  • Paz-Ares LG; Hospital Universitario 12 de Octubre, H12O-CNIO Lung Cancer Clinical Research Unit, Universidad Complutense & CiberOnc, Madrid, Spain.
  • Reck M; Airway Research Center North, German Center for Lung Research, Lung Clinic, Grosshansdorf, Germany.
  • Borghaei H; Fox Chase Cancer Center, Philadelphia, PA.
  • O'Byrne KJ; Princess Alexandra Hospital, Translational Research Institute and Queensland University of Technology, Brisbane, Queensland, Australia.
  • Gupta RG; Bristol Myers Squibb, Princeton, NJ.
  • Bushong J; Bristol Myers Squibb, Princeton, NJ.
  • Li L; Bristol Myers Squibb, Princeton, NJ.
  • Blum SI; Bristol Myers Squibb, Princeton, NJ.
  • Eccles LJ; Bristol Myers Squibb, Princeton, NJ.
  • Ramalingam SS; Winship Cancer Institute, Emory University, Atlanta, GA.
J Clin Oncol ; 41(6): 1200-1212, 2023 02 20.
Article en En | MEDLINE | ID: mdl-36223558
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Pulmón de Células no Pequeñas / Ipilimumab / Nivolumab / Neoplasias Pulmonares Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: J Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Moldova
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Pulmón de Células no Pequeñas / Ipilimumab / Nivolumab / Neoplasias Pulmonares Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: J Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Moldova